CMOP±R in the Treatment of Untreated Non-Hodgkin's Lymphoma
Status:
NOT_YET_RECRUITING
Trial end date:
2027-08-31
Target enrollment:
Participant gender:
Summary
This is a prospective, single arm, multicenter study to evaluate the safety and efficacy of CMOP±R in patients with newly diagnosed non-Hodgkin's lymphoma.
Phase:
PHASE2
Details
Lead Sponsor:
The First Affiliated Hospital of Soochow University